Goat Anti-EPM2AIP1 (EPM2A (laforin) Interacting Protein 1, FLJ11207, KIAA0766, EPM2A Interacting Protein 1)
Identification of a novel protein interacting with laforin, the EPM2a progressive myoclonus epilepsy gene product.
Applications
Suitable for use in Peptide ELISA, Immunohistochemistry and Western Blot. Other applications not tested.
Recommended Dilution
Peptide ELISA: 1:8000 Western Blot: 1-2ug/ml Immunohistochemistry: 5-10ug/ml Optimal dilutions to be determined by the researcher.
Storage and Stability
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Immunogen
Synthetic peptide corresponding to C-TRNQHTLSQPLTDEH, from the internal region (near C-terminus) of the protein sequence according to NP_055620.1. Species sequence homology: mouse, rat and canine
Form
Supplied as a liquid in Tris saline, 0.02% sodium azide, pH 7.3, 0.5% BSA.
Purity
Purified by immunoaffinity chromatography.
Specificity
Recognizes human EPM2AIP1.
